Pro-Dex, Inc. - Common Stock (PDEX)
63.23
+2.13 (3.49%)
NASDAQ · Last Trade: Apr 14th, 3:14 AM EDT
Detailed Quote
Previous Close | 61.10 |
---|---|
Open | 61.10 |
Bid | 63.01 |
Ask | 70.00 |
Day's Range | 59.95 - 65.87 |
52 Week Range | 16.83 - 65.87 |
Volume | 55,528 |
Market Cap | 206.20M |
PE Ratio (TTM) | 31.62 |
EPS (TTM) | 2.0 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 41,624 |
Chart
About Pro-Dex, Inc. - Common Stock (PDEX)
Pro-Dex Inc is a company focused on the design, development, and manufacturing of innovative medical devices and precision motion control products. They cater primarily to the healthcare sector, providing cutting-edge solutions that enhance surgical procedures and improve patient outcomes. With a commitment to quality and technological advancement, Pro-Dex works closely with healthcare professionals to ensure that their products meet the evolving needs of the medical community, ultimately aiming to contribute to advancements in patient care and medical practices. Read More
News & Press Releases
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.
Via Chartmill · April 12, 2025
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.
Via Chartmill · March 21, 2025

A fundamental analysis of (NASDAQ:PDEX): Why PRO-DEX INC (NASDAQ:PDEX) qualifies as a high growth stock.
Via Chartmill · February 28, 2025

A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) showing high EPS and FCF growth while beating expectations
Via Chartmill · February 7, 2025

IRVINE, CA / ACCESS Newswire / January 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 second quarter ended December 31, 2024. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2025 with the Securities and Exchange Commission today.
Via ACCESS Newswire · January 30, 2025

Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.
Via Investor's Business Daily · January 7, 2025

IRVINE, CA / ACCESSWIRE / September 5, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 fourth quarter and full-year ended June 30, 2024.
Via ACCESSWIRE · September 5, 2024

Via Benzinga · November 1, 2024

Via Benzinga · November 1, 2024

Via Benzinga · October 31, 2024

IRVINE, CA / ACCESSWIRE / October 31, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2025 first quarter ended September 30, 2024. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2025 with the Securities and Exchange Commission today.
Via ACCESSWIRE · October 31, 2024

Via Benzinga · September 9, 2024

PDEX stock results show that Pro-Dex missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Via InvestorPlace · May 2, 2024

IRVINE, CA / ACCESSWIRE / May 2, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 third quarter ended March 31, 2024. The Company also filed its Quarterly Report on Form 10-Q for the third quarter of fiscal year 2024 with the Securities and Exchange Commission today.
Via ACCESSWIRE · May 2, 2024

Via Benzinga · February 8, 2024

IRVINE, CA / ACCESSWIRE / February 8, 2024 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2024 second quarter ended December 31, 2023. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2024 with the Securities and Exchange Commission today.
Via ACCESSWIRE · February 8, 2024

Although the equities sector saw some impressive gains this year, there’s still time for undervalued stocks with strong growth potential.
Via InvestorPlace · December 17, 2023

IRVINE, CA / ACCESSWIRE / November 2, 2023 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2024 with the Securities and Exchange Commission today.
Via ACCESSWIRE · November 2, 2023

PHOENIX, AZ / ACCESSWIRE / October 26, 2023 / The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ:PDEX)("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets.
Via ACCESSWIRE · October 26, 2023

IRVINE, CA / ACCESSWIRE / October 13, 2023 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 fourth quarter and full-year ended June 30, 2023. The Company also filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2023, with the Securities and Exchange Commission ("SEC") today.
Via ACCESSWIRE · October 12, 2023
Phoenix, Arizona--(Newsfile Corp. - June 5, 2023) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a...
Via Newsfile · June 5, 2023

IRVINE, CA / ACCESSWIRE / May 4, 2023 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 third quarter ended March 31, 2023. The Company also filed its Quarterly Report on Form 10-Q for the third quarter of fiscal year 2023 with the Securities and Exchange Commission today.
Via ACCESSWIRE · May 4, 2023
Phoenix, Arizona--(Newsfile Corp. - February 14, 2023) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a...
Via Newsfile · February 14, 2023

IRVINE, CA / ACCESSWIRE / February 2, 2023 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 second quarter ended December 31, 2022. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2023 with the Securities and Exchange Commission today.
Via ACCESSWIRE · February 2, 2023